-
Mashup Score: 117
Single-fraction radiotherapy plus best supportive care improved pain compared with best supportive care alone in patients with liver cancer, and could be considered a standard palliative treatment.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Antecedent chromatin organization determines cGAS recruitment to ruptured micronuclei - 11 month(s) ago
Nature Communications – DNA damage-induced micronuclei are linked to downstream viral signalling through the cGAS pattern recognition receptor. Here, the authors identify features of micronuclei…
Source: www.nature.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 4SARC Meeting Before ASCO 2024 - SARC - 11 month(s) ago
Leading into the annual meeting of the American Society of Clinical Oncology (ASCO), SARC will host the first of two 2023 SARC semiannual meetings.
Source: sarctrials.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2CCTG HN13 study awarded funding in the Spring 2023 CIHR competition | Canadian Cancer Trials Group - 1 year(s) ago
CCTG HN13 clinical trial has successfully been awarded $1,602,675 in the Spring 2023 CIHR funding competition to investigate improving head and neck tumour and symptom control in patients who are unable to tolerate curative radiotherapy.
Source: www.ctg.queensu.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis - PubMed - 1 year(s) ago
Acute exposure to ionizing radiation can cause lethal damage to the gastrointestinal (GI) tract, a condition called the GI syndrome. Whether the target cells affected by radiation to cause the GI syndrome are derived from the epithelium or endothelium and whether the target cells die by apoptosis or …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 1Paid Summer Internship for Childhood Cancer Survivors - POGO - 1 year(s) ago
The First Avenue & EMBLEM Internship Program is open to young adults who have survived childhood cancer and are looking to experience one-on-one mentorship from leaders who care and support their development.Â
Source: www.pogo.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 30Postdoctoral Fellow in Cancer Epigenomics - 1 year(s) ago
Post a job in 3min, or find thousands of job offers like this one at jobRxiv!
Source: jobrxiv.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Dr. David Malkin Named 2024 AACR Fellow - 1 year(s) ago
MBP scientist Dr. David Malkin has been elected to the Fellows of the American Association for Cancer Research (AACR) Academy. The AACR Academy honours distinguished scientists like Dr. Malkin who have made major contributions to cancer research. Dr. Malkin is joining a select group of Canadians who have been named to the AACR Academy. Dr. Malkin has been recognized by the AACR for his…
Source: medbio.utoronto.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Dr. David Malkin Named 2024 AACR Fellow - 1 year(s) ago
MBP scientist Dr. David Malkin has been elected to the Fellows of the American Association for Cancer Research (AACR) Academy. The AACR Academy honours distinguished scientists like Dr. Malkin who have made major contributions to cancer research. Dr. Malkin is joining a select group of Canadians who have been named to the AACR Academy. Dr. Malkin has been recognized by the AACR for his…
Source: medbio.utoronto.caCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Addition of SBRT to Standard-of-Care Systemic Therapy in Oligoprogressive Disease - The ASCO Post - 1 year(s) ago
In the phase II CURB trial reported in The Lancet, Chiaojung Jillian Tsai, MD, PhD, and colleagues found that the addition of stereotactic body radiotherapy (SBRT) to standard-of-care systemic therapy was associated with improved progression-free survival in the total study population of patients with oligoprogressive non–small cell lung cancer (NSCLC) or breast cancer. Improvement was significant among patients with NSCLC but not among those with breast cancer. Chiaojung Jillian Tsai, MD, PhD In the
Source: ascopost.comCategories: General Medicine News, Hem/OncsTweet
Congratulations @ldawsonmd @RadMedPM @pmcancercentre @UHN @UofTDRO and colleagues across Canada for publishing CCTG HE1 in @TheLancetOncol establishing single fraction RT as an effective palliative treatment for painful liver cancer. @CDNCancerTrials https://t.co/aFw3lpyv7Z